← Leaderboards
Gregory Springett
H. Lee Moffitt Cancer Ctr & Res Inst
$1,681,270
Attributed
$1,681,270
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $346.5K · FY2009–13$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,681,270 · 1
By mechanism
R01$1,681,270 · 1
Top collaborators
No co-investigators on record.
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Daniel Sullivan$1,694,724
- Marilena Tauro$168,500
Others in their field
Top investigators on “Growth”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Albert Lazzarini · California Institute Of Technology$170,110,000
- David H Reitze · University Of Florida$170,110,000
- Garret A Fitzgerald · University Of Pennsylvania$153,184,124
- David Heimbrook · Leidos Biomedical Research, Inc.$143,966,408
- Carol Nesel · Westat$116,355,411
Research focus
GrowthHigh Throughput ScreeningGenerationsAntitumor AgentBraf GeneAdhesionsAcyltransferaseCancer CenterCancer TherapyCell LineCell ProliferationChemistryCofactorDrug DiscoveryCancer CellAntineoplastic AgentsEngineeringEnzyme InhibitionEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesEpithelial CellsExpression VectorHuman Frap1 Protein
Grant awards (5)
VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER$315,962
R01 · FY2013 · CA · contact PI
VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER$336,129
R01 · FY2012 · CA · contact PI
VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER$336,129
R01 · FY2011 · CA · contact PI
VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER$346,525
R01 · FY2010 · CA · contact PI
VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER$346,525
R01 · FY2009 · CA · contact PI